The ARF tumor suppressor controls ribosome biogenesis by regulating the RNA polymerase I transcription factor TTF-I

Area of Science:

• Molecular Biology
• Cell Biology
• Cancer Research

Background:

• The CDKN2A gene product, p14/p19(ARF) (ARF), exhibits tumor suppressor functions.
• ARF can arrest cell proliferation independently of p53/TP53, particularly in p53-negative cells.
• This proliferation arrest involves the suppression of ribosomal RNA (rRNA) synthesis.

Purpose of the Study:

• To elucidate the mechanism by which ARF suppresses rRNA synthesis in p53-negative cells.
• To investigate the role of ARF in controlling the subnuclear localization of RNA polymerase I transcription termination factor (TTF-I).
• To understand the involvement of the chaperone NPM/B23 in ARF-mediated rRNA synthesis regulation.

Main Methods:

• Investigating the subnuclear localization of TTF-I in the presence and absence of ARF.
• Analyzing the interaction between ARF and the nucleolar localization sequence of TTF-I.
• Utilizing TTF-I depletion and rescue experiments to assess its role in ARF function.
• Studying the influence of NPM/B23 on TTF-I shuttling.

Main Results:

• ARF controls the subnuclear localization of TTF-I, a key factor in rRNA synthesis.
• ARF binds to the nucleolar localization sequence of TTF-I, inhibiting its import into the nucleolus.
• This binding causes TTF-I to accumulate in the nucleoplasm, leading to suppressed rRNA synthesis.
• Depletion of TTF-I mimics ARF's effect on rRNA synthesis, and this effect is reversible with TTF-I reintroduction.

Conclusions:

• ARF regulates rRNA synthesis by modulating TTF-I nucleolar localization.
• The interaction between ARF and TTF-I's nucleolar localization sequence is critical for this regulation.
• These findings clarify the pathway of ARF-mediated rRNA suppression and highlight the role of NPM/B23.